Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Preferred Shares Issued: 2022-2023

Historic Preferred Shares Issued for Cullinan Therapeutics (CGEM) over the last 2 years, with Dec 2023 value amounting to $1.8 million.

  • Cullinan Therapeutics' Preferred Shares Issued rose 128.12% to $1.8 million in Q1 2023 from the same period last year, while for Mar 2023 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2023, which is 23.16% down from last year.
  • Cullinan Therapeutics' Preferred Shares Issued amounted to $1.8 million in FY2023, which was down 23.16% from $2.4 million recorded in FY2022.
  • In the past 5 years, Cullinan Therapeutics' Preferred Shares Issued registered a high of $2.4 million during FY2022, and its lowest value of $1.8 million during FY2023.
  • In the last 2 years, Cullinan Therapeutics' Preferred Shares Issued had a median value of $2.1 million in 2022 and averaged $2.1 million.
  • Data for Cullinan Therapeutics' Preferred Shares Issued shows a maximum YoY decreased of 23.16% (in 2023) over the last 5 years.
  • Over the past 2 years, Cullinan Therapeutics' Preferred Shares Issued (Yearly) stood at $2.4 million in 2022, then decreased by 23.16% to $1.8 million in 2023.